Effect of Curcuma zeodaria in Spasmodic Menstrual pain

Efficacy of Zaranbad (Curcuma zeodaria) in Primary Dysmenorrhoea: A Single Blind Randomized Controlled Trial. - nil

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090303

Enrollment

Registered

2025-07-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Zaranbad (Curcuma zeodaria): Powder of Zaranbad (Curcuma zeodaria) is made after identification and purification of drug. Then 1 gram (one masha) powder of Zaranbad is filled in capsu

Eligibility

Inclusion criteria

Inclusion criteria: All unmarried and married women aged between 18 to 30 years of age with no pelvic pathology. Regular painful menstrual cycle graded by V.A.S scale (score more than grade 3) and V.R.S scale (score more than 0).

Exclusion criteria

Exclusion criteria: All unmarried and married women aged between 18 to 30 years of age with pelvic pathology. Pregnant females. Lactating Females. Females taking O.C.P.

Design outcomes

Primary

Measure	Time frame
Relief in intensity of pain during menstrual cycleTimepoint: 2months	—

Secondary

Measure	Time frame
Improvement in quality of life.Timepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Mariyam Roqaiya

State Takmeel-ut-Tib College and Hospital, Lucknow

dr.mroqaiya@gmail.com9632560839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026